Socialize

Moderna says COVID-19 vaccine appears to be nearly 95% effective in ongoing study

Moderna said Monday its COVID-19 vaccine is proving highly effective in a major trial, a second ray of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide.

The company said its vaccine appears to be 94.5% effective, according to preliminary data from Moderna’s ongoing study. A week ago, competitor Pfizer Inc. announced its own vaccine appeared similarly effective — news that puts both companies on track to seek permission within weeks for emergency use in the U.S.

The results are “truly striking,” said Dr. Anthony Fauci, the U.S. government’s top infectious diseases expert. Earlier this year, Fauci said he would be happy with a COVID-19 vaccine that was 60% effective.

A vaccine can’t come fast enough, as virus cases topped 11 million in the U.S. over the weekend — 1 million of them recorded in just the past week — and governors and mayors are ratcheting up restrictions ahead of Thanksgiving. The pandemic has killed more than 1.3 million people worldwide, over 245,000 of them in the U.S.

Stocks rallied on Wall Street and elsewhere around the world on rising hopes that the global economy could start returning to normal in the coming months. Moderna was up 7.5% in the morning, while companies that have benefited from the stay-at-home economy were down, including Zoom, Peloton and Netflix.

Dr. Stephen Hoge, Moderna’s president, welcomed the “really important milestone” but said having similar results from two different companies is what’s most reassuring.

“That should give us all hope that actually a vaccine is going to be able to stop this pandemic and hopefully get us back to our lives,” Hoge told The Associated Press. He added: “It won’t be Moderna alone that solves this problem. It’s going to require many vaccines” to meet the global demand.

The National Institutes of Health helped create the vaccine Moderna is manufacturing, and NIH’s director, Dr. Francis Collins, said the exciting news from two companies “gives us a lot of confidence that we’re on the path towards having effective vaccines.”

But “we’re also at this really dark time,” he warned, saying people can’t let down their guard during the months it will take for doses of any vaccines cleared by the Food and Drug Administration to start reaching a large share of the population.

Scientists not involved with the testing were encouraged by the early findings but cautioned that the FDA still must scrutinize the safety data and decide whether to allow vaccinations outside of a research study.

Oxford coronavirus vaccine induces strong immune response, early trial results suggest(Opens in a new browser tab)

Comments

comments

Powered by Facebook Comments

2 Responses to Moderna says COVID-19 vaccine appears to be nearly 95% effective in ongoing study

  1. Virus Reply

    November 17, 2020 at 12:54 pm

    Since 5-10% virus rate, wonder if seniors will opt to take chance of getting the virus.

  2. Vacccines Reply

    November 17, 2020 at 4:19 pm

    Wonder how many seniors are interested in these vaccines, since they have 5-10% rate of coming down with the Covid19

    Walmart RX is giving free flu shots.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.